Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-040091

Director sold 75,000 shares at $130.34 ($9,775,500)

From the SEC's structured data for this filing

Trades in this filing

Barry Richard · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-06-27 Sale : show line 1 in the form −75,000 $130.34 $9,775,500 3,170,432 D
Open-market sales · 75,000 sh · avg $130.34 · $9,775,500
Loading xslF345X03/doc4.xml…